The administrative core, Core A, will provide administrative and fiscal management for the projects and cores of the P01. The goals are to organize staff administer the projects and cores in conjunction with project leaders, core directors and institutional staff, organize and conduct monthly meetings of P01 participants and annual meetings of P01 participants and the Scientific Advisory Board (SAB), prepare the necessary documents related to P01 activities, including reports of P01 investigator meetings and the SAB, and prepare progress reports for official agencies, facilitate interaction between individual projects and between projects and cores and monitor the progress of the individual projects on a regular basis, to maintain appropriate fiscal oversight of the projects and cords and prepare necessary fiscal reports of official agencies, and to assure compliance with appropriate regulations regarding experimentation with human subjects including gender and minor participation an vertebrate animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA142106-09
Application #
8377017
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2012-05-09
Budget End
2013-03-31
Support Year
9
Fiscal Year
2012
Total Cost
$59,253
Indirect Cost
$20,323
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Cutler, Corey S; Koreth, John; Ritz, Jerome (2017) Mechanistic approaches for the prevention and treatment of chronic GVHD. Blood 129:22-29
Ho, Vincent T; Kim, Haesook T; Bavli, Natalie et al. (2017) Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT. Blood Adv 1:2269-2279
Gartlan, Kate H; Bommiasamy, Hemamalini; Paz, Katelyn et al. (2017) A critical role for donor-derived IL-22 in cutaneous chronic GVHD. Am J Transplant :
MacDonald, Kelli Pa; Blazar, Bruce R; Hill, Geoffrey R (2017) Cytokine mediators of chronic graft-versus-host disease. J Clin Invest 127:2452-2463
MacDonald, Kelli P A; Hill, Geoffrey R; Blazar, Bruce R (2017) Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood 129:13-21
Wang, Kathy S; Kim, Haesook T; Nikiforow, Sarah et al. (2017) Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease. Blood 130:2889-2899
Asano, Takeru; Meguri, Yusuke; Yoshioka, Takanori et al. (2017) PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood 129:2186-2197
Du, Jing; Paz, Katelyn; Flynn, Ryan et al. (2017) Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-? production. Blood 129:2570-2580
McKenna Jr, David H; Sumstad, Darin; Kadidlo, Diane M et al. (2017) Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials. Cytotherapy 19:250-262
Du, Jing; Paz, Katelyn; Thangavelu, Govindarajan et al. (2017) Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells. Blood 129:3121-3125

Showing the most recent 10 out of 186 publications